Use of igf-ii/igf-iie binding for the treatment and prevention of systemic sclerosis associated pulmonary fibrosis

作者: Edward H. Cohen

DOI:

关键词:

摘要: Methods of using proteins that bind to IGF-II and/or IGF-IIE for the treatment or prevention systemic sclerosis-associated pulmonary fibrosis are described.

参考文章(65)
G. M. Grass, J. R. Robinson, Sustained- and controlled-release drug delivery systems Drugs and the pharmaceutical sciences. ,vol. 40, pp. 635- 671 ,(1978)
Vera S. Byers, Robert William Baldwin, Monoclonal Antibodies for Cancer Detection and Therapy ,(1985)
Buck A. Rhodes, Scott W. Burchiel, Radioimmunoimaging and radioimmunotherapy Elsevier. ,(1983)
Isaac J. Rondon, Timothy A. Springer, Motomu Shimaoka, Edward H. Cohen, Conformation specific antibodies ,(2005)
Kenya Shitara, Kazuyasu Nakamura, Yuji Ohki, Recombinant antibody against human insulin-like growth factor ,(2004)
Roberto De Pascalis, Makoto Iwahashi, Midori Tamura, Eduardo A. Padlan, Noreen R. Gonzales, Ameurfina D. Santos, Mariateresa Giuliano, Peter Schuck, Jeffrey Schlom, Syed V. S. Kashmiri, Grafting of “Abbreviated” Complementarity-Determining Regions Containing Specificity-Determining Residues Essential for Ligand Contact to Engineer a Less Immunogenic Humanized Monoclonal Antibody The Journal of Immunology. ,vol. 169, pp. 3076- 3084 ,(2002) , 10.4049/JIMMUNOL.169.6.3076